Evidence map›Paper›PMID 31180607›Full record

SynthesisAddiction (Abingdon, England)2019

Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis.

Emily Stockings, Lucy Thi Tran, Thomas Santo, Amy Peacock, Sarah Larney, Damian Santomauro, Michael Farrell, Louisa Degenhardt

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Addiction (Abingdon, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Emily StockingsNational Drug and Alcohol Research Centre (NDARC), UNSW Sydney, Sydney, Australia.ORCID 0000-0001-5349-951X
Lucy Thi TranNational Drug and Alcohol Research Centre (NDARC), UNSW Sydney, Sydney, Australia.ORCID 0000-0002-9711-1596
Thomas SantoNational Drug and Alcohol Research Centre (NDARC), UNSW Sydney, Sydney, Australia.ORCID 0000-0002-1218-3946
Amy PeacockNational Drug and Alcohol Research Centre (NDARC), UNSW Sydney, Sydney, Australia.ORCID 0000-0002-5705-2026
Sarah LarneyNational Drug and Alcohol Research Centre (NDARC), UNSW Sydney, Sydney, Australia.ORCID 0000-0002-5602-4963
Damian SantomauroQueensland Centre for Mental Health Research and School of Public Health, University of Queensland, Australia.ORCID 0000-0002-6630-5435
Michael FarrellNational Drug and Alcohol Research Centre (NDARC), UNSW Sydney, Sydney, Australia.ORCID 0000-0001-7008-8130
Louisa DegenhardtNational Drug and Alcohol Research Centre (NDARC), UNSW Sydney, Sydney, Australia.ORCID 0000-0002-8513-2218

Funding

Using existing data to understand and ameliorate risk in opioid agonist therapyR01DA044170 · NIDA · UNIVERSITY OF NEW SOUTH WALES · PI DEGENHARDT, LOUISA · 2017 to 2019
$641k
Department of Health and Ageing, Australian GovernmentNational Health and Medical Research CouncilNHMRC Research Fellowships #1104600NHMRC Research Fellowships #1109366NHMRC Research Fellowships GNT1041742NHMRC Research Fellowships GNT1091878NHMRC Research Fellowships GNT1135991NHMRC Research Fellowships GNT1140938NIDA NIH HHS R01 DA044170NIH HHS R01DA1104470
6 · The paper itself

Abstract

BACKGROUND AND

aimsAmphetamines are the second most commonly used class of illicit drugs. We aimed to produce pooled estimates of mortality risks among people with regular or dependent use of amphetamines, with a focus upon all-cause mortality as well as specific causes of death.

designSystematic review and meta-analysis of cohorts of people with problematic use or dependence on amphetamines with data on all-cause or cause-specific mortality. SETTING AND

participantsOf 4240 papers, 30 were eligible, reporting on 25 cohorts that measured all-cause mortality, drug poisoning, suicide, accidental injuries, homicide and cardiovascular mortality. Cohorts (n = 35-74 139) were in North America, several Nordic countries and Asia Pacific. MEASUREMENT: Titles/abstracts were independently screened by one reviewer and excluded those reviewed by a second reviewer. Full-text screening was by two reviewers with discrepancies resolved via a third reviewer. We extracted data on crude mortality rates (CMR) per 100 person-years (py), standardized mortality ratios (SMRs). We imputed SMRs where possible if not reported by study authors. We also calculated mortality relative risks. Data were pooled using random-effects models; potential reasons for heterogeneity were explored using subgroup analyses and meta-regressions.

findingsTwenty-three cohorts contributed data for the pooled all-cause CMR: 1.14 per 100 py [95% confidence interval (CI) = 0.92-1.42]. Pooled cause-specific mortality rates were: drug poisoning, 0.14 per 100 py (95% CI = 0.06-0.34); cardiovascular disease, 0.13 per 100 py (95% CI = 0.06-0.29); suicide, 0.20 per 100 py (95% CI = 0.07-0.55); accidental injury, 0.20 per 100 py (95% CI = 0.08-0.47) and homicide, 0.03 per 100 py (95% CI = 0.02-0.06). There was substantial heterogeneity for all pooled CMR estimates except homicide. The pooled all-cause SMR was 6.83 (95% CI = 5.27-8.84). Pooled cause-specific SMRS were: poisoning, 24.70 (95% CI = 16.67, 36.58); homicide, 11.90 (95% CI = 7.82-18.12); suicide, 12.20 (95% CI = 4.89-30.47); cardiovascular disease, 5.12 (95% CI = 3.74-7.00) and accidental injury, 5.12 (95% CI = 2.88-9.08).

conclusionsPeople with regular or dependent amphetamine use are at elevated risk of a range of causes of mortality compared with people without regular or dependent amphetamine use.

Indexed as

Accidental InjuriesAmphetamine-Related DisordersAmphetaminesAsiaCardiovascular DiseasesCohort StudiesHomicideHumansNorth AmericaRiskScandinavian and Nordic CountriesSuicideAmphetaminesAmphetaminescohort studiesmeta-analysismortalitystimulantssystematic review

Identifiers

PMID31180607
PMCPMC6732053

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.